Objective: Hot flashes are classic symptoms of menopause. Emerging data link hot flashes to cardiovascular disease (CVD) risk, yet whether hot flashes are related to brain health is poorly understood. We examined the relationship between hot flashes (measured via physiologic monitor and self-report) and white matter hyperintensities (WMH) among midlife women.
H ot flashes are the cardinal symptom of the menopausal transition, experienced by more than 70% of women during the menopausal transition. 1 They have long been understood to be associated with reductions across all domains of quality of life. 2 However, hot flashes have recently been shown to be associated with indices of physical health.
Several studies have shown hot flashes to be associated with elevated subclinical cardiovascular disease (CVD), including poorer endothelial function, greater intima-media thickness, and aortic calcification. 3, 4 Hot flashes have also been linked to an adverse CVD risk factor profile, including elevated blood pressure, 5 higher lipids, 6 greater insulin resistance, 7 and a more procoagulant hemostatic profile. 8 Furthermore, hot flashes, particularly those measured physiologically, have been associated with decreased cardiac vagal control. 9 Notably, associations between hot flashes and CVD risk indices persist after adjusting for other standard CVD risk factors.
The existing literature on hot flashes has largely focused on changes in peripheral physiology. Although hot flashes are conceptualized as largely a central nervous system event, 10 very few studies have examined hot flashes in relation to brain health. Elevated traditional and novel CVD risk factors, such as hypertension, insulin resistance, and autonomic nervous system dysfunction, have been associated with adverse changes in the brain, notably lesions in the white matter. [11] [12] [13] These lesions appear as white matter hyperintensities (WMH) on T2-weighted magnetic resonance imaging (MRI) scans and are thought to develop because of small vessel disease in the brain. 14 WMH are linked to later stroke, cognitive decline and dementia, and mortality. 15 No studies have examined whether hot flashes are linked to WMH in the brain.
We tested whether wake and sleep hot flashes were associated with WMH. We tested these hypotheses in a sample of midlife women who underwent both brain imaging and detailed ambulatory diary and physiologic hot flash monitoring. We considered the roles of a range of potential explanatory factors and confounders in observed associations.
METHODS

Study sample
Twenty women-a subcohort of a larger parent study of hot flashes (N ¼ 300)-underwent brain imaging and cognitive assessment. Parent study inclusion criteria were as follows: aged 40 to 60 years; nonsmoking; with intact uterus and at least one ovary; not pregnant; late perimenopausal or postmenopausal (no menstrual period in the prior 2 mo); without a history of heart disease, stroke, arrhythmia, or breast cancer; and did not take hormone therapy, selective serotonin reuptake inhibitor/serotonin norepinephrine reuptake inhibitor antidepressants, clonidine, b blockers, calcium channel blockers, gabapentin, or insulin within 3 months. Additional criteria for inclusion in the brain imaging substudy included the following: no metal in the body and no history of chronic migraine, concussion, stroke, brain injury, or Parkinson's disease. Of the 20 women who underwent the brain imaging protocol, one woman experienced hot flash monitor failure; thus, 19 women were included in the analyses.
Design and procedures
The parent study protocol included anthropometric measures, questionnaires, blood specimens, and a 3-day ambulatory hot flash assessment protocol. Women in the brain imaging substudy additionally underwent MRI of the brain. Procedures were approved by the University of Pittsburgh Institutional Review Board. All participants provided written informed consent.
Hot flashes
Hot flash monitoring was conducted with an ambulatory sternal skin conductance monitor, which women wore for 24 hours, and with an electronic hot flash diary, which women carried for 3 days (the first day of which coincided with physiologic hot flash monitoring). Sternal skin conductance was recorded via the VU University Ambulatory Monitoring System monitor (VU University, Amsterdam, the Netherlands), a portable device worn in a pouch around the waist. This device measures sternal skin conductance sampled at 1 Hz from the sternum via a 0.5-V constant voltage circuit passed between two Ag/AgCl electrodes (UFI, Morro Bay, CA) filled with 0.05 mol/L KCl Velvachol/glycol paste. 16a,16b Participants were instructed to avoid exercising and showering during monitoring. Physiologic hot flashes were classified via standard methods; a skin conductance rise of 2 mmho/ 30 seconds 17 was flagged automatically by DPS version 3.6 software (UFI) and edited for artifact. 18 Given that some women showed submaximal hot flashes that failed to reach the 2-mmho criterion, 19, 20 all potential hot flash events (submaximal hot flashes showing the characteristic hot flash pattern 18 ) were also visually inspected. Events that showed the characteristic hot flash pattern but whose rise was less than 2 mmho/30 seconds were coded as hot flashes and independently verified by two coders-a coding approach that has been shown to be reliable (k ¼ 0.86). 19, 20 A 20-minute lockout period was implemented after the start of the flash, during which no hot flashes were coded. For reporting of hot flashes during the 3-day monitoring period, participants were instructed to (1) complete a portable electronic diary (Palm Z22; Palm Inc) and (2) press event mark buttons on their wrist actigraph and on the hot flash monitor (24 h only) when experiencing a hot flash. For reporting of nighttime hot flashes, women were instructed to report hot flashes via button press.
Brain imaging
MRI scanning was performed at the MR Research Center of the University of Pittsburgh. We used a 3-T Siemens Tim Trio magnetic resonance scanner with a Siemens 12-channel head coil. Two series of magnetic resonance images were analyzed for the current study: magnetization-prepared rapid gradient echo (MPRAGE) T1-weighted sequence and T2-weighted fluid-attenuated inversion recovery (FLAIR) sequence. MPRAGE images were acquired on the axial plane: repetition time, 2,300 milliseconds; echo time, 3.43 milliseconds; inversion time, 900 milliseconds; flip angle, 98; slice thickness, 1 mm; field of view, 256 Â 224 mm; voxel size, 1 mm Â 1 mm; matrix size, 256 Â 224; number of slices, 176. FLAIR images were acquired on the axial plane: repetition time, 9,160 milliseconds; echo time, 89 milliseconds; inversion time, 2,500 milliseconds; flip angle, 1508; field of view, 256 Â 212 mm; slice thickness, 3 mm; matrix size, 256 Â 240; number of slices, 48 slices; voxel size, 1 mm Â 1 mm.
WMH volume was obtained from the MPRAGE and T2weighted FLAIR images using an automated method for quantifying and localizing WMH. 21 WMH quantification was performed using a fuzzy-connected algorithm. 22 Total WMH volume was normalized by total brain volume.
Sleep
Participants wore a wrist actigraph and completed a sleep diary for 3 days during the monitoring period. Actigraphy data in 1-minute epochs were collected with a Minimitter Actiwatch-2 (Respironics Inc, Murrysville, PA) and analyzed with Actiware software (version 6.0.1). Sleep diary data for bedtime and rise time were entered for calculation of sleep-wake variables. Actigraphy outcome variables included total sleep time (within the interval between bedtime and rise time), sleep latency (bedtime to first sleep period), wakefulness after sleep onset (total minutes of wakefulness between sleep onset and final wake time), and sleep efficiency (100% Â total sleep time/time in bed). Participants also completed the Pittsburgh Sleep Quality Index, 23 Epworth Sleepiness Scale, 24a and Berlin Questionnaire 25 -widely used and well-validated measures of sleep quality, daytime sleepiness, and sleep apnea, respectively.
Covariates
Height was measured with a fixed stadiometer, and weight was measured with a balance beam scale; body mass index (BMI) was calculated as weight (kg) / height (m) 2 . Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were the mean of the second and third of three seated measurements taken via Dinamap model 100. Demographics, medical history, and health behaviors were assessed by questionnaires and interview. Menopause status was obtained from reported bleeding patterns, categorized as perimenopausal (>2 to <12 mo of amenorrhea) or postmenopausal (!12 mo amenorrhea). 24b Race/ethnicity was self-reported by participants. Education was assessed as years of completed education and classified as less than college or college or higher (owing to small cell sizes) for analysis. Self-rated health was rated on a six-point Likert scale from excellent to very poor. Depressive symptoms were assessed via the Center for Epidemiologic Studies Depression Scale. 24c Participants provided a morning fasting blood sample for assessment of glucose, insulin, and lipids, assessed via direct reagent/antibody measurement or indirect calculation methods. Glucose, total cholesterol, and triglycerides were determined enzymatically in serum (Vital Diagnostics, Lincoln, RI). High-density lipoprotein was determined after selective precipitation by heparin/manganese chloride and centrifugal removal of very-low-density lipoprotein and low-density lipoprotein (LDL). LDL was calculated indirectly using the Friedewald equation. 26 Insulin was measured by cross-reactivity of human proinsulin antibody via radioimmunoassay (EMD Millipore, St Charles, MO). Homeostatic model assessment (HOMA), an index reflecting insulin resistance, was calculated as: (fasting insulin Â fasting glucose) / 22.5. 27 High-sensitivity C-reactive protein (hsCRP) was measured using goat anti-C-reactive protein (CRP) antibodies (Beckman-Coulter, Brea, CA) and measured turbidimetrically using increase in absorbance (AU400; Olympus America Inc, Melville, NY), with intra-assay and interassay coefficients of variation of 5.5% and 3.0%, respectively. Interleukin-6 (IL-6) was measured using a high-sensitivity enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN), with intra-assay and interassay coefficients of variation of 9.1% and 10.2%, respectively. Serum estradiol (E 2 ) was assessed using liquid chromatography-tandem mass spectrometry, with interassay and intraassay coefficients of variation of 5.0% and 8.1%, respectively, and a lower limit of detection of 1.0 pg/mL. 28 
Statistical analysis
Variables were examined for distribution, outliers, and cell sizes. To account for variations in monitoring time, we calculated hot flash rates, with the number of hot flashes divided by monitoring time and standardized to a 24-hour period. They were also separated into sleep and wake hot flashes defined by Actiwatch sleep and wake times. For women without hot flashes, hot flash rates were set to 0. Associations between hot flashes and WMH were tested in linear regression models, controlling for a priori selected covariates (age, race/ethnicity, and BMI). Additional covariates were added in secondary models. WMH was considered both as an untransformed variable and as a log-transformed variable. Results were comparable; thus, untransformed data are presented here. E 2 , HOMA, IL-6, and hsCRP values were log-transformed to conform to assumptions of normality. All tests were two-tailed, with a set to 0.05. Analyses were conducted using SAS (version 9.4, SAS Institute, Cary, NC).
RESULTS
Participants were, on average, 55 years old, normotensive, overweight, and postmenopausal. Approximately a quarter of women were African American, with the remainder being non-Hispanic white ( Table 1 ). Nine women reported having had hot flashes; yet, on physiologic monitoring, 14 women showed physiologic hot flashes-consistent with a prior finding that women tend to underreport hot flashes relative to physiologic monitoring. 29 For the sample as a whole, women reported a mean of 3 hot flashes/24 hours and showed 8 hot flashes/24 hours on physiologic monitoring.
When considered categorically, women with hot flashes (physiologically verified) had marginally higher WMH relative to women without hot flashes (b [SE] ¼ 0.0009 [0.0004], P ¼ 0.07), controlling for age, race, and BMI. Considered continuously, more physiologic hot flashes, We performed several additional analyses to determine whether other potential covariates might relate to hot flashes and might modify the relationship between hot flashes and WMH. These covariates included education, SBP, DBP, menopause stage, lipids, HOMA, use of blood pressurelowering medication, prior hormone therapy use, self-rated health, depressive symptoms, IL-6, and hsCRP. Higher LDL cholesterol (per unit increase in LDL: b [SE] ¼ 0.00003 [0.000008], P ¼ 0.01) and higher hsCRP log (per unit increase in hsCRP log : b [SE] ¼ 0.0005 [0.0002], P ¼ 0.01) were associated with more WMH (both models adjusted for age, race, BMI, and sleep physiologic hot flashes). None of the other factors (education, SBP, DBP, menopause stage, high-density lipoprotein, triglycerides, HOMA, use of blood pressurelowering medication, prior hormone therapy use, self-rated health, depressive symptoms, and IL-6) were significantly related to WMH. Furthermore, inclusion of any of these factors (including LDL and hsCRP) in models for sleep physiologic hot flashes and WMH did not substantially alter the findings (data not shown). Furthermore, we considered E 2log concentrations in the relationship between sleep physiologic hot flashes and WMH in models adjusted for age, race, and BMI; the relationship between sleep physiologic hot flashes and WMH persisted (per additional hot flash: b
[SE] ¼ 0.0002 [0.0001], P < 0.05).
DISCUSSION
This study was the first to investigate the relationship between menopausal hot flashes and WMH. We showed that more physiologically monitored hot flashes during sleep were associated with greater WMH burden among midlife women without clinical cardiovascular or cerebrovascular disease. These associations did not account for demographic factors, CVD risk factors, sleep, E 2 , or other potential confounding factors. These findings demonstrate a link between menopausal hot flashes and brain health, specifically structural abnormalities associated with ischemic disease.
Some studies have linked hot flashes to elevated subclinical CVD and a more adverse CVD risk factor profile. [3] [4] [5] [6] [7] [8] Notably, a more adverse CVD risk profile, particularly hypertension and diabetes, has been associated with more WMH, which may reflect small vessel disease in the brain. 11, 12 Greater WMH burden in turn has been linked to elevated risks of stroke, dementia, and mortality. 15 Thus, these data suggest that the adverse CVD profile observed in the periphery in some studies may extend to the brain. Importantly, the direction of relationships cannot be assumed here. Hot flashes may serve as a marker for underlying white matter changes, they may be etiologically involved in these changes in women, or the relationship between WMH and hot flashes may be explained by a third factor. The precise nature of the relationship between hot flashes and WMH should be investigated in future work, including longitudinal studies. 
THURSTON ET AL
Prior work has considered other reproductive and hormonal factors (such as hormone therapy use, pregnancy, and preeclampsia) in relation to WMH. 30, 31 However, no prior work has considered menopausal hot flashes in relation to WMH. WMH can be observed among relatively healthy midlife women, and some pieces of evidence indicate that WMH may be particularly related to novel CVD risk factors compared with traditional CVD risk factors in this group. 32 Furthermore, prior work has demonstrated that reproductive factors, such as bilateral oophorectomy during premenopause or perimenopause (which typically induces hot flashes), have been linked to elevated risks of cognitive impairment, dementia, and parkinsonism. 33, 34 Midlife reproductive phenomena, such as hot flashes, may be particularly relevant to later brain health. Future work should extend the present findings to a wider range of clinical and functional (ie, cognitive) outcomes and to other populations, such as women undergoing oophorectomy.
Findings were primarily for physiologically assessed hot flashes. Physiologically monitored hot flashes differ from self-reported hot flashes in several important ways. Physiologic hot flash measures have the advantage of not relying on attention, perception, emotional influences, or adherence to hot flash reporting protocols. 35 These issues are particularly relevant in the ambulatory setting, which presents many distractions and competing activities. Thus, typically more hot flashes are detected than are reported in the ambulatory setting. 29 Physiologic hot flash measures may be particularly useful for measuring sleep hot flashes when reporting may be particularly difficult and impacted by the quality of sleep itself. 36 Finally, compared with self-reported hot flashes, physiologically monitored hot flashes have been shown to be more strongly related to indices such as cardiac vagal control 9 and cognitive indices such as verbal memory. 37 Findings were most pronounced for physiologically monitored hot flashes detected during sleep. These relationships did not seem to be accounted for by sleep characteristics assessed both by actigraphy and by questionnaire. In fact, only daytime sleepiness was related to greater WMH burden, and sleepiness did not account for the observed associations. Notably, sleep apnea was related to WMH in another study 38 but was not related to WMH in this study, and sleep apnea is not typically related to hot flashes. 39 Although sleep was rigorously assessed here, a role for sleep cannot be definitively ruled out without polysomnographic measures of sleep. However, the evidence here does not support a major role for sleep in these associations. The relationships between physiologic hot flashes and other relevant outcomes (such as cardiac vagal control 9 and cognition 37 ) seem to be most pronounced for sleep hot flashes. Whether sleep hot flashes and waking hot flashes have different underlying physiologies is not known, and further investigation of the unique relationship between sleep hot flashes and WMH is warranted.
The mechanisms linking hot flashes to WMH are not entirely clear; however, the findings here were not altered after controlling for CVD risk factors (such as blood pressure, BMI, or lipids). Inflammation has been tied to WMH 40 and possibly hot flashes. 41 We considered IL-6 and CRP here; although CRP was related to WMH, neither marker explained the association between hot flashes and WMH. Furthermore, hot flashes typically occur in the context of E 2 withdrawal, 10 which may have implications for brain health. 42 However, findings persisted after controlling for E 2 , which was measured via gold standard methods that are sensitive to low E 2 levels observed in postmenopausal women. Notably, as the timing of E 2 withdrawal may be relevant to brain health, 42 future work with larger sample sizes should consider variations in the timing of hot flashes in relation to WMH. Other studies have shown an autonomic nervous system profile characterized by increased sympathetic and/or decreased vagal control of the heart associated with hot flashes 9 and WMH, 13 which may be a candidate pathway linking these two phenomena. Future work should further consider the mechanisms by which hot flashes may be associated with WMH.
This study has several limitations. The main limitation of the study was its small size, which may have limited power to detect associations. Such consistent findings were noted between WMH and hot flashes despite this small sample, and findings should be replicated in future work. Most of the women included here were postmenopausal; thus, any differences by menopause stage could not be investigated. Although extensive sleep indices were included, future work should examine the role of sleep in these relationships, using additional measures such as polysomnography.
This study had several strengths. This is the first study to investigate menopausal hot flashes in relation to WMH. Hot flashes were investigated via physiologic monitoring and prospective diary report, and during wake and sleep as women went about their daily activities. Women completed a detailed brain imaging procedure. Moreover, other related important indices (including sleep, depression, CVD risk factors, and rigorously measured endogenous E 2 concentrations) were assessed and their roles were considered.
CONCLUSIONS
More menopausal hot flashes, particularly hot flashes occurring during sleep hours, are associated with greater WMH burden among midlife women without clinical cardiovascular or cerebrovascular disease. This study is the first study to investigate hot flashes in relation to WMH, showing that changes in white matter can occur early in life among women with hot flashes during sleep. These findings underscore the importance of the brain in investigating propensity for hot flashes, their underlying physiology, and their sequelae.
